Adient (ADNT) PT Raised to $26 at UBS
UBS analyst Joseph Spak raised the price target on Adient (NYSE: ADNT) to $26.00 (from $25.00) while maintaining a Neutral ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)